![](https://www.medicinesforeurope.com/wp-content/uploads/2016/03/twitter.png)
![](https://www.medicinesforeurope.com/wp-content/uploads/2016/03/Logo_LinkedIn_round.png)
![](https://www.medicinesforeurope.com/wp-content/uploads/2016/03/youtube.png)
![](https://www.medicinesforeurope.com/wp-content/uploads/2016/03/flickr.png)
Over the last two years, major crises have had dramatic impacts on patient population health across Europe. The COVID-19 pandemic disrupted the provision of primary care, cancer screening and treatment, care continuity, and elective surgery, impacting health outcomes of patients across Europe. The 2022 Health at a Glance Report, examined the key challenges to develop stronger, more resilient health systems following the acute phase of the COVID-19 pandemic.